Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management
Go back to Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management| (NASDAQ: GPCR) | Delayed: 22.51 -0.37 (1.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.88 | 52 Week High | $ | |||
| Open | $23.00 | 52 Week Low | $ | |||
| Day High | $23.32 | P/E | N/A | |||
| Day Low | $22.03 | EPS | $ | |||
| Volume | 234,540 | |||||



